CLINICAL MANIFESTATIONS OF HYPERPROLACTINEMIA Part of “CHAPTER 13 – PROLACTIN AND ITS DISORDERS“ The amenorrhea-galactorrhea syndrome is the classic description of the clinical manifestation of hyperprolactinemia. However, a spectrum of…
CLINICAL ASPECTS OF PROLACTIN PHYSIOLOGY Part of “CHAPTER 13 – PROLACTIN AND ITS DISORDERS“ The physiologic causes of hyperprolactinemia are summarized in Table 13-1. The following sections describe clinical aspects…
NORMAL CONTROL OF PROLACTIN SECRETION Part of “CHAPTER 13 – PROLACTIN AND ITS DISORDERS“ Prolactin secretion is controlled by dual inhibitory and stimula-tory factors (Fig. 13-1). This hormone is unique…
PROLACTIN AND ITS DISORDERS Laurence Katznelson Anne Klibanski NORMAL CONTROL OF PROLACTIN SECRETION CLINICAL ASPECTS OF PROLACTIN PHYSIOLOGY CLINICAL MANIFESTATIONS OF HYPERPROLACTINEMIA Related posts: DIABETES INSIPIDUS REPRESSION OF BASAL TRANSCRIPTION/COREPRESSORS…
ABNORMAL SECRETION OF GROWTH HORMONE Part of “CHAPTER 12 – GROWTH HORMONE AND ITS DISORDERS“ DEFICIENCY OF GROWTH HORMONE GH deficiency results from various causes, and the clinical manifestations depend…
MEASUREMENT OF PLASMA GROWTH HORMONE Part of “CHAPTER 12 – GROWTH HORMONE AND ITS DISORDERS“ The measurement of GH in blood is problematic because of the heterogeneous nature of GH….
ACTIONS OF GROWTH HORMONE Part of “CHAPTER 12 – GROWTH HORMONE AND ITS DISORDERS“ Growth hormone has numerous biologic actions, many occurring in concert to enhance protein anabolism and tissue…
REGULATION OF THE GROWTH HORMONE RECEPTOR AND BINDING PROTEIN Part of “CHAPTER 12 – GROWTH HORMONE AND ITS DISORDERS“ For reasons of accessibility, little is known about the regulation of…
SOMATOTROPE DEVELOPMENT AND GROWTH HORMONE Part of “CHAPTER 12 – GROWTH HORMONE AND ITS DISORDERS“ Several pituitary transcription factors are involved in pituitary somatotrope development. Their consideration is important here…
